These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2857819)

  • 1. Antimoniotungstate (HPA 23) treatment of three patients with AIDS and one with prodrome.
    Rozenbaum W; Dormont D; Spire B; Vilmer E; Gentilini M; Griscelli C; Montagnier L; Barre-Sinoussi F; Chermann JC
    Lancet; 1985 Feb; 1(8426):450-1. PubMed ID: 2857819
    [No Abstract]   [Full Text] [Related]  

  • 2. Anti-AIDS agents show varying early results in vitro and in vivo.
    Riesenberg DE; Marwick C
    JAMA; 1985 Nov; 254(18):2521, 2527, 2529. PubMed ID: 2997490
    [No Abstract]   [Full Text] [Related]  

  • 3. Therapeutic trials with HPA23, alpha-IFN and ribavirin in AIDS patients.
    Moroni M; Lazzarin A; Orlando G; Crocchiolo P; Castagna A; Verani P
    Chemioterapia; 1987 Jun; 6(2 Suppl):639-41. PubMed ID: 3509513
    [No Abstract]   [Full Text] [Related]  

  • 4. Prospects of therapy for infections with human T-lymphotropic virus type III.
    Hirsch MS; Kaplan JC
    Ann Intern Med; 1985 Nov; 103(5):750-5. PubMed ID: 2413793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Experimental chemotherapy of AIDS].
    Rada B
    Cas Lek Cesk; 1988 May; 127(22):677-83. PubMed ID: 3293790
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunologic reconstitution in the acquired immunodeficiency syndrome.
    Lane HC; Fauci AS
    Ann Intern Med; 1985 Nov; 103(5):714-8. PubMed ID: 2996405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiviral drugs for AIDS. Current status and future prospects.
    Sandström E
    Drugs; 1986 Jun; 31(6):463-6. PubMed ID: 2942386
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical trial of tolerance of HPA-23 in patients with acquired immune deficiency syndrome.
    Moskovitz BL
    Antimicrob Agents Chemother; 1988 Sep; 32(9):1300-3. PubMed ID: 3058016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiviral therapy in AIDS. Clinical pharmacological properties and therapeutic experience to date.
    Sandström EG; Kaplan JC
    Drugs; 1987 Sep; 34(3):372-90. PubMed ID: 2824170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reverse transcriptase activity (RTA) in lymphocyte cultures of AIDS patients treated with HPA-23.
    Buimovici-Klein E; Ong KR; Lange M; Englard A; McKinley GF; Reddy M; Grieco MH; Cooper LZ
    AIDS Res; 1986; 2(4):279-83. PubMed ID: 2434115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progress in the development of antiviral therapy for HTLV-III-associated diseases.
    Yarchoan R; Broder S
    Important Adv Oncol; 1987; ():293-311. PubMed ID: 2841232
    [No Abstract]   [Full Text] [Related]  

  • 12. Reverse transcriptase activity (RTA) in lymphocyte cultures of HIV-infected patients receiving short treatments of HPA 23. A biological evaluation.
    Vittecoq D; Woerle R; Barre-Sinoussi F; Chermann JC
    Biomed Pharmacother; 1988; 42(1):35-9. PubMed ID: 2457397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toxicity of HPA-23 (ammonium-21-tungsto-9-antimoniate) for normal human myeloid progenitor cells (GM-CFU) in vitro.
    Aymard JP; Ferry R; Janot C; Schooneman F; Legras B; May T; Streiff F
    Biomed Pharmacother; 1989; 43(6):451-4. PubMed ID: 2590721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AIDS: the virus, antivirals and vaccines.
    Weber J
    Br J Hosp Med; 1987 Feb; 37(2):135-7, 140-1. PubMed ID: 2950962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ammonium-5-tungsto-2-antimoniate (HPA23) can prevent fox rabies.
    Pepin M; Blancou J
    Arch Virol; 1985; 83(3-4):327-9. PubMed ID: 3970678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of HPA-23 antiviral activity in HIV-infected patients without AIDS.
    Burgard M; Sansonetti P; Vittecoq D; Descamps P; Guetard D; Herson S; Rozenbaum W; Rouzioux C
    AIDS; 1989 Oct; 3(10):665-8. PubMed ID: 2480798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The antiviral compound HPA-23 can prevent scrapie when administered at the time of infection.
    Kimberlin RH; Walker CA
    Arch Virol; 1983; 78(1-2):9-18. PubMed ID: 6686005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo effect of a new mineral condensed ion (HPA 39) on murine Friend leukaemia.
    Larnicol N; Augery Y; Le Bousse-Kerdiles C; Degiorgis V; Chermann JC; Teze A; Jasmin C
    J Gen Virol; 1981 Jul; 55(Pt 1):17-23. PubMed ID: 7299368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of rabies in mice and foxes with antiviral compounds.
    Bussereau F; Picard M; Blancou J; Sureau P
    Acta Virol; 1988 Jan; 32(1):33-49. PubMed ID: 2897770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of scrapie infection in mice by heteropolyanion 23, dextran sulfate, and some other polyanions.
    Kimberlin RH; Walker CA
    Antimicrob Agents Chemother; 1986 Sep; 30(3):409-13. PubMed ID: 2430521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.